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The ubiquitin-proteasome and autophagy-lysosome
systems are major proteolytic pathways, whereas
function of theUb-independent proteasomepathway
is yet to be clarified. Here, we investigated roles of the
Ub-independent REGg-proteasome proteolytic sys-
tem in regulating metabolism. We demonstrate that
mice deficient for the proteasome activator REGg
exhibit dramatic autophagy induction and are pro-
tected against high-fat diet (HFD)-induced liver stea-
tosis through autophagy. Molecularly, prevention of
steatosis in the absence of REGg entails elevated
SirT1, a deacetylase regulating autophagy andmeta-
bolism. REGg physically binds to SirT1, promotes
its Ub-independent degradation, and inhibits its
activity to deacetylate autophagy-related proteins,
thereby inhibiting autophagy under normal condi-
tions. Moreover, REGg and SirT1 dissociate from
each other through a phosphorylation-dependent
mechanism under energy-deprived conditions, un-
leashing SirT1 to stimulate autophagy. These obser-
vations provide a function of the REGg proteasome
in autophagy and hepatosteatosis, underscoring
mechanistically a crosstalk between the proteasome
and autophagy degradation system in the regulation
of lipid homeostasis.
INTRODUCTION
Macroautophagy (hereafter referred to as autophagy) is a
conserved degradative process that is essential for cellular380 Cell Metabolism 18, 380–391, September 3, 2013 ª2013 Elseviehomeostasis and quality control and mediates degradation of
damaged or excess proteins and organelles in lysosomes
(Mizushima, 2007). Its dysregulation is involved in many physio-
logical disorders and human diseases (Mizushima, 2007).
Recent studies reveal that autophagy is required for breakdown
of lipid droplets, and inhibition of autophagy leads to steatosis
and fatty liver inmice (Czaja, 2010; Singh et al., 2009). Autophagy
also regulates adipocyte differentiation and fat storage (Zhang
et al., 2009). These findings present autophagy as a therapeutic
target that could potentially be manipulated to treat diseases
accompanied by excess lipid accumulation (Singh and Cuervo,
2012). Nevertheless, regulatory factors linking autophagy and
lipid metabolisms urgently await discovery.
SirT1 (yeast Sir2) is a protein deacetylase that acts as amaster
metabolic sensor of NAD+ and has been reported to modulate
lifespan and cellular metabolism (Guarente, 2000). SirT1 reduces
fat accumulation in white adipose (Picard et al., 2004) and pro-
motes browning of white adipose (Qiang et al., 2012). SirT1 over-
expression reduces high-fat diet (HFD)-induced steatosis and
improves insulin sensitivity (Pfluger et al., 2008), whereas loss
of SirT1 leads to liver steatosis and inflammation (Purushotham
et al., 2009). In addition, SirT1 provides a cell survival advantage
in response to stress by deacetylating a number of substrates,
such as p53 (Luo et al., 2001) and FOXOs (Brunet et al., 2004).
SirT1 can be regulated by FOXO3a, p53, and HIC1 at the level
of transcription (Chen et al., 2005; Nemoto et al., 2004) and is
regulated by DBC1 through protein-protein interaction (Zhao
et al., 2008). SirT1 expression is augmented following fasting
(Nemoto et al., 2004). We previously reported that DNA
damaging agents also induce SirT1 expression (Wang et al.,
2006). Importantly, overexpression of SirT1 stimulates auto-
phagy, and SirT1 knockout (KO) MEF cells cannot fully activate
autophagy under starved conditions (Lee et al., 2008). However,
molecular factors andmechanisms that control SirT1 autophagic
function are largely unexplored.r Inc.
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Figure 1. REGg Regulates Fat Accumula-
tion, and REGg-Deficient Mice Are Pro-
tected from High-Fat Diet-Induced Liver
Steatosis
(A) Food intake of wild-type (WT) or REGg-
knockout (KO)malemice on HFD (n = 4). REGg-KO
mice exhibited increased food consumption. Data
represent mean ± SD, **p < 0.01.
(B and C) REGg-KO mice are protected against
HFD-induced liver steatosis. Livers were examined
in mice fed with HFD for 19 weeks. (B) Liver tissues
were stained with hematoxylin and eosin (H&E).
Pictures were taken using a microscopy with 103
and 203 object lenses. The lipid droplets
appeared as uncolored circles in the HE stained
tissue slide. (C) Representative liver images (upper
panel) and liver/body weight ratios (lower panel)
after 19 weeks of HFD feeding.
(D) Representative images for oil red O staining of
lipid droplet accumulation in frozen liver sections
of mice fed with standard chow diet (CD) or HFD
for 19 weeks (scale bar, 50 mm).
(E and F) Total triglyceride (TG) levels in liver (E) and
serum (F) of mice fed with CD or HFD for 19 weeks.
Data represent mean ± SD (n = 3), *p < 0.05. See
also Figure S1.
Cell Metabolism
REGg Proteasome Regulates Lipid MetabolismThe proteasome is a large protein complex consisting of a
20S proteolytic core and three proteasomal activators, 19S (or
PA700), 11S (or PA28, REG), and PA200. The 19S activator binds
to the 20S core and primarily mediates degradation of ubiquiti-
nated proteins. The 11S activator binds to the proteasome and
mainly promotes Ub-independent degradation. However, little
attention has been paid to the Ub-independent proteolysis in
eukaryotes. Our investigations have revealed that REGg (or
PA28g), one of the 11S proteasomal activators (Dubiel et al.,
1992; Ma et al., 1992), promotes Ub-independent degradation
of SRC-3 and p21 (Li et al., 2006, 2007). In this study, we found
that REGg knockout (REGg-KO) mice exhibit autophagy and
are protected against HFD-induced liver steatosis through
enhanced autophagy. REGg also serves as a master regulator
in switch off/on autophagy under normal and energy-deprivation
conditions by regulating SirT1. Our findings suggest that REGg is
a potential therapeutic target for disordered lipid metabolism.
RESULTS
REGg Plays a Role in Regulating Lipid Metabolism
and HFD-Induced Liver Steatosis
REGg-KO mice were reported to display reduced body weight
and growth retardation (Barton et al., 2004; Murata et al.,
1999). This prompted us to investigate the functional role of
REGg in metabolism. To determine if and how REGg expression
impacts lipid metabolism in vivo, we challenged REGg-KO mice
with a HFD. Interestingly, we observed a slightly increased foodCell Metabolism 18, 380–391, Sintake in REGg-KO mice on HFD (Fig-
ure 1A). Loss of REGg had a significant
beneficial effect in mice, preventing
them from developing liver steatosis after
19 weeks of HFD (Figures 1B and 1C) incomparison with the wild-type (WT) littermates, despite the
fact that they had similar weight gains during HFD feeding (Fig-
ure S1A). Differential lipid metabolism in these mice was further
demonstrated by classic oil red O staining of livers, showing that
the REGg-KO mice exhibited a marked reduction of HFD-
induced hepatic lipid accumulation (Figure 1D, upper panel);
mice with standard chow diet (CD) had few noticeable changes
(Figure 1D, lower panel). Quantification of the liver and serum
triglyceride (TG) levels in mice confirmed that REGg-KO
mice were resistant to HFD-induced liver steatosis (Figures 1E
and 1F). These data support that REGg-KO mice are protected
from HFD-induced hepatic steatosis.
In addition, REGg overexpression led to an increase of total
lipid accumulation as well as an increase in size of lipid droplets
in human hepatocellular carcinoma (HepG2) cells, effects that
are further exaggerated after oleate treatment (Figure S1B),
whereas transient overexpression of REGa or REGb, two homol-
ogous proteasome activators (Dubiel et al., 1992; Ma et al.,
1992), had no such effect (Figure S1C). Collectively, the above
data revealed a role for REGg in regulating hepatic lipid meta-
bolism and a protective outcome against HFD-induced liver
steatosis in REGg-KO mice.
Deficiency of REGg Triggers Autophagy
To clarify the effect of REGg on lipid metabolism, we examined
mRNA expression of a number of lipid transport, lipogenesis,
and fatty acid oxidation genes in the liver of REGg-WT
and -KO mice (Figure S1D). However, there was no significanteptember 3, 2013 ª2013 Elsevier Inc. 381
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Figure 2. REGg Deficiency Triggers Auto-
phagy
(A) Transmission electron microscopy of liver tis-
sues from REGg-WT and -KO mice (n = 3) with CD
or HFD for 19 weeks. * indicates lipid droplet (LD)
(bright round organelle). Images 1–5 are high
magnifications of the ‘‘white box’’ areas indicated
in the images of KO-CD and KO-HFD. The arrows
show autophagic vacuoles (AVs) containing LDs,
other cargos, or mixed cargos; the arrow heads
show AVs in LDs. The average numbers and sizes
of AVs and LDswere quantified (lower panels). The
average number of AVs, lipid numbers, and lipid
size were determined from a randomly selected
pool of 5–10 fields under each condition. Data
represent mean ± SD, **p < 0.01.
(B and C) The protein levels of autophagy markers
p62 and LC3 in livers (B) and cerebellums (C) of
three pairs of REGg-WT and -KO mice maintained
on a standard CD or HFD for 19 weeks were
determined by western blot. The relative average
levels of LC3-II/I or p62/actin under each condition
were quantified by densitometry of immunoblot
signals and are presented below the blots.
(D) The protein levels of LC3 and p62 in REGg-WT
and -KO MEF cell lines were detected by western
blot. To determine the specific effect for REGg,
REGg-KO MEF cells were infected with lentiviral
vectors expressing Flag-tagged REGg, REGa, or
REGb for 48 hr.
(E and F) Protein levels of LC3 and p62 in HeLa and
H1299 cells with stable knockdown of REGg (ShR)
or a vector control (ShN) were determined by
western blot. See also Figure S2.
Cell Metabolism
REGg Proteasome Regulates Lipid Metabolismchange in the expression of selected genes between REGg-WT
and -KOmouse livers. Next, we examined fatty acid uptake, lipid
synthesis, and fatty acid b-oxidation in primary hepatic cells from
livers of REGg-WT and -KO mice. The REGg-deficient hepatic
cells showed no significant alterations in fatty acid uptake or lipid
synthesis, but exhibited a slight but significant increase in fatty
acid b-oxidation after pretreatment with fatty acids (Figures
S1E–S1G). These data suggest that the protection of HFD-
induced hepatic steatosis in REGg-KO mice is likely associated
with increased lipid oxidation.
Recent studies reveal that autophagy promotes lipid droplet
breakdown and the rate of fatty acid b-oxidation increased dur-
ing lipid loading, but to amuch lesser extent in cells with inhibited382 Cell Metabolism 18, 380–391, September 3, 2013 ª2013 Elsevier Inc.autophagy (Singh et al., 2009). Moreover,
autophagy is critical for b-oxidation of
fatty acids in the liver (Sinha et al.,
2012). Therefore, we tested whether
REGg regulates liver steatosis via auto-
phagy. Transmission electron micro-
scopic analysis of liver autophagy in
REGg-WT and -KO mice revealed that
REGg knockout led to a marked increase
of the number of autophagic vacuoles
(AVs) in vivo (Figure 2A). Mice fed a HFD
have reduced hepatic autophagy (Yang
et al., 2010). Similarly, our data showedthe number of AVs in liver sections decreased after HFD treat-
ment, but the number of AVs in HFD-treated REGg-KO mice still
maintain at a certain level in comparison with REGg-WT mice on
HFD. In addition, we also observed AVs that enwrapped lipid
droplets (Figure 2A #2 and #4) or mixed lipid droplets and AVs
(Figure 2A #3) in liver sections of REGg-KO mice on HFD.
HFD-treated REGg-WT mice displayed robust accumulation of
large lipid droplets, whereas HFD-fed REGg-KO mice showed
amarked reduction of both the number and the size of lipid drop-
lets (Figure 2A). These results indicate that REGg deficiency
induces autophagy in mouse liver and that the protection of
HFD-induced hepatic steatosis in REGg-KO mice may result
from increased autophagy.
Cell Metabolism
REGg Proteasome Regulates Lipid MetabolismNext, we examined the levels of autophagy markers in the
livers of REGg-KO and -WT mice fed with CD or HFD for
19 weeks (Figure 2B). Results showed a remarkably increased
LC3-II and a clearly decreased p62 in REGg-KO livers with a
standard CD. HFD led to a marked decrease in LC3-II and an
accumulation of p62 in both REGg-WT and -KO mouse livers,
but HFD-treated REGg-KO mice still maintain higher autophagy
levels than REGg-WT mice with HFD, indicating that autophagy
levels are always higher in REGg-KO mice than in WT at given
diet. In addition, REGg-KO mice exhibited a decreased p62
and an increased LC3-II in cerebellum (Figure 2C). Reduced
p62 and enhanced LC3-II were also observed in REGg-KO
MEF cells as well as HeLa and H1299 cells with REGg stable
knockdown (Figures 2D–2F). Moreover, expression of an
RNAi-resistant REGg, but not REGa/b, restored REGg defi-
ciency-induced autophagy, indicating the specificity of REGg
in its inhibition of autophagy (Figure 2D).
To further assess the role of REGg in autophagy, we evalu-
ated autophagic flux in REGg-WT and -KO MEFs treated with
or without bafilomycin A1 (Ba), which inhibits fusion between
autophagosomes and lysosomes (Figure S2A). Results showed
that in the presence of Ba, loss of REGg also results in an
increased accumulation of LC3-II under both normal and
starvation conditions, indicating that the differences in LC3-II
levels in REGg-WT and -KO MEF cell lines were due to auto-
phagic induction rather than a blockade at downstream
steps. The inhibitory effect of REGg on autophagy was further
confirmed by quantitation of GFP-LC3 puncta forma-
tion. REGg-deficient cells displayed an increase in both the
number of punctate LC3 per cell and the GFP-LC3 punctae-
positive cells (Figures S2B and S2C). Therefore, normal REGg
expression keeps autophagy at a low level under basal
conditions.
REGg Inhibits Autophagy in a SirT1-Dependent Manner
under Normal Conditions
Previous studies demonstrate that suppression of the ubiquitin
proteasome system induces ER stress, and autophagy can be
activated by ER stress (Ding et al., 2007a). Moreover, ER stress
contributes to metabolic dysfunction and hepatic steatosis, and
a fundamental change is observed in hepatic ER function in
obesity from protein to lipid synthesis and metabolism (Fu
et al., 2011, 2012). To assess whether ER stress may be involved
in REGg deficiency-induced autophagy and hepatic steatosis
resistance, we examined the status of ER homeostasis in
REGg-KO or -knockdown cells in the presence or absence of
an ER stress inducer, thapsigargin (Figures S2D–S2F). Neverthe-
less, REGg deficiency exhibited no significant effect due to ER
stress under normal or thapsigargin-treated conditions. These
results suggest that REGg deficiency-induced autophagy is
not likely due to ER stress.
To understand the molecular basis of REGg-mediated regula-
tion of autophagy, we carried out a large-scale proteomic screen
using antibody array (Fullmoon Biosystems Inc.) and a reverse-
phase protein array (RPPA) to identify proteins differentially
regulated in REGg-positive and REGg null MEF cells (X.L. and
S.H., unpublished work). The Fullmoon arrays contain antibodies
against phospho and total proteins (Bernier et al., 2011), and
RPPA assays include additional proteins not present in theCell MeFullmoon array, together covering nearly 1,400 proteins in
more than 30 different pathways. In the RPPA analysis, we
discovered that SirT1 enhancement in REGg null MEFs was
statistically significant, similar to the significant changes in the
positive controls of the known REGg targets, p53 and p21, in
REGg null MEFs (Figure S3A). The fact that REGg-KO triggers
autophagy (Figure 2) and SirT1 overexpression stimulates auto-
phagy motivated us to test whether REGg affects autophagy by
negatively regulating SirT1.
First, we assessed whether REGg interacts with SirT1. Results
showed that SirT1 coprecipitated with REGg in 293T cells over-
expressing GFP-REGg and Flag-SirT1 (Figure 3A). Endogenous
REGg binds to SirT1 but not other sirtuins such as SirT2
(Figure 3B). The direct association between REGg and SirT1
was verified in vitro (Figure 3C). Moreover, a region of SirT1 (aa
378–458) within the catalytic domain and a region corresponding
to aa 66–103 in REGg is essential for REGg-SirT1 interaction
(Figures S3B and S3C). These results indicate that REGg is a
SirT1-interacting protein.
Next, we evaluated whether REGg regulates autophagy via
SirT1. Concomitant expression of REGg inhibited SirT1-
induced conversion of LC3-I to LC3-II (Figure 3D) and formation
of GFP-LC3 punctae (Figures 3E and 3F). Increased LC3-II and
reduced p62 were observed in REGg-only knockdown cells,
but not in cells with REGg/SirT1 double knockdown (Figure 3G).
In parallel, REGg knockdown increased the number of LC3
punctae per cell and GFP-LC3 punctae-positive cells, whereas
REGg/SirT1 double knockdown exhibited little change in the
number of the LC3 punctae and the percentage of punctae-
positive cells (Figures 3H and 3I). These results indicate that
endogenous SirT1 is required for REGg deficiency-induced
autophagy.
REGg Mediates Ub-Independent Degradation of SirT1
Next, we examined whether REGg is involved in SirT1 degrada-
tion. Results showed a strong negative correlation between
REGg and SirT1 expression in vivo (Figures 4A and 4B). Stable
knockdown of REGg results in elevated SirT1 expression (Fig-
ure 4C). We also observed increased SirT1 expression in
REGg-KO MEF cells, and restoration of REGg expression in
these cells repressed SirT1 expression (Figure 4D). However,
REGg deficiency had no effect on SirT1 transcript levels (Fig-
ure 4E). Moreover, REGg overexpression instigated a reduction
of endogenous SirT1 protein (Figure 4F) and increased SirT1
degradation (Figure 4G). In contrast, the rate of SirT1 decay
was markedly delayed in both REGg-knockdown HeLa cells
(Figure 4H) and REGg-KO MEFs (Figure 4I), indicating that
endogenous REGg expression renders SirT1 unstable. Using
a ts85 cell line, which harbors a thermolabile ubiquitin-acti-
vating enzyme that abolishes the transfer of ubiquitin to target
proteins at nonpermissive temperatures (37C) (Li et al.,
2007), we observed a slower degradation rate in SirT1 at
37C compared to that at 30C, while REGg overexpression
could still promote SirT1 degradation at 37C (Figure S4A).
REGg overexpression had no effect on SirT1 ubiquitination,
whereas treatment with proteasome inhibitor MG132 only
mildly increased the level of ubiquitinated SirT1 (Figure S4B).
These data indicate that REGg induces SirT1 degradation in
an Ub-independent manner.tabolism 18, 380–391, September 3, 2013 ª2013 Elsevier Inc. 383
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Figure 3. REGg Inhibits Autophagy in a
SirT1-Dependent Manner under Normal
Conditions
(A–C) REGg interacts with SirT1. (A) Flag-SirT1 and
GFP-REGg were expressed in the 293T cells and
immunoprecipitated with FLAG-M2 agarose
beads, and coprecipitated REGg was detected by
western blot. (B) Endogenous REGg in HeLa cells
was precipitated using anti-REGg antibody or with
IgG (Mock IP), and coprecipitated SirT1 and SirT2
were detected by western blot. (C) REGg interacts
with SirT1 in vitro. His-tagged SirT1 was incubated
with GST-REGg or GST proteins for 4 hr at 4C.
REGg-SirT1 coprecipitation was determined by
GST pull-down and western blot.
(D–F) REGg inhibits SirT1 autophagic function. (D)
HeLa cells were transfected with indicated plas-
mids for 30 hr. The conversion of LC3-I to LC3-II
and levels of p62 were determined by western
blot. (E) REGg inhibits SirT1-stimulated GFP-LC3
punctae formation. HeLa cells seeded on cover-
slips were transfected with GFP-LC3 and indi-
cated plasmids for 30 hr and GFP-LC3 were
visualized by fluorescence microscopy. (F) The
percentages of GFP-LC3-positive cells with GFP-
LC3 punctae and the GFP-LC3 punctae per cell in
(E) were quantified. Data represent mean ± SD,
**p < 0.01.
(G–I) SirT1 is required for REGg-deficient
induced autophagy. (G) SirT1-knockdown attenu-
ates REGg-knockdown-induced LC3-II accumu-
lation and p62 reduction. HeLa cells with stable
knockdown of SirT1 (SirT1-Si) or control vectors
(Mock-Si) were infected with pLL3.7 vector (ShN)
or REGg-knockdown (ShR) lentivirus for 72 hr. Cell
lysates were western blotted for SirT1, REGg,
LC3, and p62. (H) SirT1-knockdown represses
REGg-knockdown-induced formation of GFP-LC3
punctae. Cells in (G) were transiently transfected
with GFP-LC3 for 20 hr and visualized by fluores-
cence microscopy. (I) The percentages of GFP-
LC3-positive cells with GFP-LC3 punctae and the
GFP-LC3 punctae per cell in (H) were quantified.
Data represent mean ± SD, **p < 0.01. See also
Figure S3.
Cell Metabolism
REGg Proteasome Regulates Lipid MetabolismREGg Inhibits SirT1-Mediated Deacetylation of the
Autophagy Machinery
SirT1 stimulates autophagy by deacetylating Atg5, Atg7, and
Atg8 (Lee et al., 2008). Since SirT1 is required for REGg
deficiency-induced autophagy (Figures 3G–3I), we hypothesize
that REGg regulates autophagy via SirT1-mediated deacetyla-
tion of Atg proteins. As expected, REGg-KO reduced acetylation
levels of Atg5/Atg7 in primary hepatocytes, and pharmacological
inhibition of SirT1 with nicotinamide (NAM) blocked REGg defi-
ciency-induced Atg5/Atg7 deacetylation (Figure 5A). Acetylation
of ULK1 (Atg1) (Lin et al., 2012) and Atg3 promote autophagy (Yi
et al., 2012). However, Atg5/Atg7 but not Atg1/Atg3 bind to SirT1
(Figure S5A), and REGg overexpression could not affect Atg1/
Atg3 acetylation (data not shown). Taken together, we believe
that SirT1-dependent deacetylation of Atg5/Atg7 contributes to
REGg deficiency-induced autophagy.384 Cell Metabolism 18, 380–391, September 3, 2013 ª2013 ElsevieNext, we examined whether overexpression of REGg can alter
SirT1 deacetylase activity on Atg5/Atg7. To avoid REGg-induced
degradation of SirT1, increasing amounts of SirT1 expression
plasmids (++) were cotransfected with REGg. Results showed
that REGg inhibited SirT1-mediated deacetylation of Atg5/Atg7
(Figures5Band5C), indicating thatREGgdirectly inhibitsSirT1ac-
tivity in deacetylating Atg5/Atg7. Interestingly, REGg has no effect
on SirT1-induced deacetylation of p53 (Figure S5B), suggesting a
specific role for REGg in regulating of autophagy complex.
To further address why REGg selectively inhibits SirT1-
induced deacetylation of Atg5/Atg7, we checked whether
REGg competes with Atg proteins for SirT1 binding. Overexpres-
sion of REGg inhibited SirT1 binding to Atg5/Atg7 (Figures 5D
and 5E). Restoring expression of REGg in REGg-KO MEF cells
reduced endogenous SirT1-Atg7 interaction under low dose of
MG132 treatment (Figure S5C). REGg also displaces Atg7 fromr Inc.
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Figure 4. REGg Mediates Degradation of
SirT1
(A–E) REGg deficiency causes accumulation of
endogenous SirT1. (A and B) SirT1 protein levels in
liver, testis, cerebellum, and muscle tissues of
REGg-WT and -KO mice were examined by
western blot (A) and immunohistochemical stain-
ing (B). (C) H1299 and HeLa cells were stably
infected with control lentivirus (ShN) or lentivirus
expressing REGg siRNA (ShR) and analyzed for
REGg, SirT1, and p53 expression levels by west-
ern blot. (D) MEFs from REGg-WT and -KO mice
were analyzed for REGg and SirT1 expression
levels by western blot. To restore REGg expres-
sion, REGg-KO MEFs were infected with a lenti-
viral vector expressing REGg for 48 hr. (E) Relative
mRNA expression of SirT1 in REGg-deficient cells
was examined by quantitative real-time PCR
analysis. Data represent mean ± SD (n = 3).
(F) 293T, HeLa, and H1299 cells were transfected
with a control vector or Flag-REGg plasmid for
36 hr; cell extracts were subjected to western
blotting.
(G–I) REGg promotes SirT1 degradation. HeLa
cells infected with control lentivirus or lentivirus
overexpressing REGg for 24 hr (G), HeLa cells
stably expressing a control lentivirus (ShN) or a
lentiviral REGg shRNA (ShR) (H), or MEFs cells
from REGg-WT and -KO mice (I) were treated with
translation inhibitor cycloheximide (CHX, 50 mg/ml)
and analyzed for SirT1 stability by western blot.
See also Figure S4.
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REGg Proteasome Regulates Lipid MetabolismSirT1 in vitro in a dose-dependent manner (Figure 5F). These
results suggest that REGg-induced SirT1-Atg5/Atg7 dissocia-
tion also contributes to its inhibitory effect on autophagy.
The above data strongly endorse a specific inhibitory effect of
REGg on SirT1-mediated Atg5/Atg7 deacetylation. Paradoxi-
cally, REGg is mostly localized in nucleus, while Atg5/Atg7
proteins are largely cytosolic. Therefore, we examined how
SirT1 mediates functional links between the REGg and Atg5/
Atg7 in mouse primary hepatocytes. Results from immunostain-
ing showed that both REGg and SirT1 were localized primarily in
the nucleus (Figure S5D). Most of the previous studies observed
REGg primarily localized in nucleus, whereas a few studies
also showed a cytoplasm-localized REGg (Wo´jcik, 1999). We
observed that a small fraction of REGg localized into the cyto-
plasm, lack of REGg leads to an accumulation of SirT1 notCell Metabolism 18, 380–391, Sonly in nucleus but also in cytoplasm,
and Atg5/Atg7 are found in both the cyto-
plasm and nucleus (Figure S5D). These
results suggest that each of these pro-
teins might dynamically shuttle between
nucleus and cytoplasm, although major
localization and competition could be in
one or two compartments.
Next, we determined in vivo regulation
of Atg5/Atg7 acetylation by REGg (Fig-
ure 5G). Results showed that REGg defi-
ciencymarkedly reduced hepatic acetyla-
tion levels of Atg5/Atg7 in both CD- andHFD-treated mice. HFD treatment increased levels of Atg5/Atg7
acetylation, but HFD-induced hepatic accumulation of acetyl-
Atg5/Atg7 is much less in REGg-KO mice in comparison with
WT mice. These results indicate that the REGg-SirT1-Atg-auto-
phagy signaling pathway is involved in regulating HFD-induced
hepatic steatosis in vivo. Taken together, our data suggest that
REGg binds to SirT1, promotes SirT1 degradation, disrupts the
interaction of SirT1-Atg5/Atg7, and specifically inhibits SirT1
activity for deacetylating Atg proteins, which then keeps cellular
autophagy at a basal level under physiological conditions.
REGg Controls Hepatic Steatosis through a SirT1- and
Autophagy-Dependent Mechanism
Next, we tested whether REGg regulates hepatic cellular steato-
sis in a SirT1- and autophagy-dependent manner. We observedeptember 3, 2013 ª2013 Elsevier Inc. 385
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Figure 5. REGgRegulates SirT1 Autophagic
Function by Inhibiting Its Binding to and
Deacetylating Autophagy Complex
(A) REGg regulates acetylation states of Atg5 and
Atg7 through SirT1. REGg-WT and -KO primary
hepatocytes were treated with or without NAM
(5 mM, 12 hr); cell extracts were immunoprecipi-
tated by anti-acetyl-lysine antibody (Ac IP). The
immunoprecipitates were subjected to western
blotting with anti-Atg5 or -Atg7 antibody.
(B and C) 293T cells were cotransfected with
indicated plasmids and acetylated proteins were
immunoprecipitated by anti-acetyl-lysine antibody
(Ac IP). To ensure equal expression of SirT1, more
SirT1 plasmid DNA (++) was cotransfected with
REGg. The acetylation levels of Atg5/Atg7 protein
were determined by western blot using anti-Myc
tag antibody.
(D and E) REGg inhibits SirT1 binding to Atg5/Atg7.
293T cells transfected with indicated plasmids and
Flag-tagged Atg5/Atg7 were immunoprecipitated
using FLAG-M2 agarose beads followed by
western blot. To ensure equal expression of SirT1,
more SirT1 plasmid DNA (++) was cotransfected
with REGg.
(F) REGg inhibits SirT1-Atg7 binding in vitro. GST-
SirT1 was incubated with His-Atg7 in the presence
or absence of His-REGg for 4 hr at 4C, followed
by GST pull-down and western blot.
(G) REGg regulates Atg5 and Atg7 acetylation
in vivo. The acetylation status of Atg5 and Atg7
were measured in hepatocytes from REGg-WT
and -KOmice on theCD or HFD for 19weeks. Liver
tissue lysates were immunoprecipitated by anti-
acetyl-lysine antibody (Ac IP), and the endogenous
acetylation levels of Atg5 and Atg7 proteins were
determined by western blot using anti-Atg5 or
-Atg7 antibodies. See also Figure S5.
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REGg Proteasome Regulates Lipid Metabolismthat absence of REGg was associated with accumulation of
LC3-II/SirT1 and reciprocal reduction of p62 in primary hepato-
cytes isolated from REGg-KO mice (Figure 6A). REGg-KO led
to a significantly reduced accumulation of intracellular lipids in
oleate-palmitate-treated primary hepatocytes, whereas 3-MA
(autophagy inhibitor) and NAM (SirT1 inhibitor) both had a signif-
icant inhibitory effect on REGg deficiency-mediated clearance of
cellular lipids (Figures 6B and 6C). Similar results were observed
in REGg-knockdown HepG2 cells (Figures S6A–S6C). These
data suggest that SirT1 and autophagy are both required
for the protective effect against hepatic steatosis in REGg-defi-
cient mice.
To further address the contributions of autophagy in REGg
deficiency-induced prevention of HFD-induced fatty liver in vivo,
REGg-WT and -KO mice were fed HFD for 7 weeks accompa-386 Cell Metabolism 18, 380–391, September 3, 2013 ª2013 Elsevier Inc.nied with simultaneous intraperitoneal
injection of the autophagy inhibitor chlo-
roquine (CLQ) or vehicle during the last
3 weeks. By H&E staining of frozen liver
sections and liver TG measurements, we
found that 7 weeks of HFD treatment
already led to a small but significant
increase of lipid droplets and TG levelsin livers of REGg-WT, but not REGg-KO mice (Figures 6D and
6E). Remarkably, CLQ treatment highly increased accumulation
of large lipid droplets and TG levels in livers of both REGg-KO
and -WT mice on HFD. More importantly, the differences
betweenREGg-WT and -KOmice in levels of TG and lipid droplet
accumulation on HFD disappeared following cotreatment with
CLQ. The effect of CLQ to inhibit autophagy was confirmed by
western blot analysis of LC3-II accumulation (Figure 6F). These
results indicate that inhibiting autophagy eliminates the protec-
tive roles of REGg deficiency in HFD-induced liver steatosis,
substantiating that autophagy is required for REGg-mediated
regulation of hepatic lipid metabolism. Interestingly, increased
REGg-SirT1 association was observed after oleate treatment
(Figure S6D), suggesting that REGg-SirT1 association may
contribute toHFD-induced hepatic steatosis. Collectively, these
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Figure 6. REGg Deficiency Attenuates
Hepatic Steatosis through a SirT1- and
Autophagy-Dependent Mechanism
(A) REGg-KO increased levels of SirT1 and auto-
phagy in hepatocytes. Protein levels of SirT1, p62,
and LC3 in primary hepatocytes isolated from
REGg-WT and -KO mice were determined by
western blot.
(B) REGg knockout attenuates fatty acid-induced
hepatic cellular steatosis. REGg-WT and -KO pri-
mary hepatocytes were treated with or without
0.3 mM oleate/palmitate (2:1) for 20 hr in the
presence of autophagy inhibitor 3-methyladenine
(3-MA, 5mM) or SirT1 inhibitor nicotinamide (NAM,
5 mM), followed by BODIPY 493/503 staining and
visualized by fluorescence microscopy.
(C) Cells of (B) were analyzed for total TG levels.
Data represent mean ± SD, *p < 0.05, **p < 0.01,
NS = nonsignificant.
(D–F) REGg-proteasome regulates hepatic lipid
metabolism through inhibition of autophagy.
REGg-WT and REGg-KO mice were fed with
standard chow diet (CD) or high-fat diet (HFD) for
7 weeks (mice began on HFD 3 weeks after birth).
Four weeks after HFD, mice (n = 3) were treated
with intraperitoneal injection of chloroquine (CLQ,
60 mg/kg body weight) every other day along with
continued HFD for another 3 weeks. (D) Liver tis-
sues were stained with H&E. Pictures were taken
using a microscopy with 203 object lenses. The
lipid droplets appeared as uncolored circles in the
H&E-stained tissue slide. (E) Total triglyceride (TG)
levels of livers in (D) were measured. Data repre-
sent mean ± SD (n = 3), *p < 0.05, **p < 0.01. (F)
Liver tissue lysates in (D) were subjected to west-
ern blot. CLQ elicits an accumulation of LC3-II in
HFD-treated mice, indicating inhibition of auto-
phagy. See also Figure S6.
Cell Metabolism
REGg Proteasome Regulates Lipid Metabolismresultsdemonstrate that theREGg-proteasome regulateshepatic
lipid metabolism through SirT1 and autophagy pathways.
Energy Starvation Dissociates REGg-SirT1 and
Releases SirT1 to Stimulate Autophagy
Autophagy occurs at relatively low levels under basal condi-
tions, but can be induced by a variety of nutrient and intracel-
lular stresses (Kroemer et al., 2010); we therefore examined the
impact of starvation on REGg-SirT1 interactions. As a result,
glucose deprivation (GD) significantly reduced REGg-SirT1
binding (Figure 7A). In parallel, REGg-SirT1 binding was
reduced in cells treated with 2-deoxy-D-glucose (2DG), a
potent inhibitor of glucose metabolism that mimics the effect
of GD (Figure 7B). In a reciprocal fashion, GD increased
the binding of SirT1 to Atg7 (Figure 7C). These results indi-Cell Metabolism 18, 380–391, Scate that energy deprivation entails
SirT1-REGg dissociation and thus re-
leases SirT1 to bind to and deacetylate
Atg proteins, setting off the autophagic
process.
Phosphorylation was found to modu-
late the function of SirT1 in cell prolifera-
tion (Nasrin et al., 2009). To test whetherphosphorylation is involved in starvation-induced SirT1-REGg
dissociation, we generated SirT1 phospho-S14-, phospho-
T530-, and phospho-T719-specific antibodies (Figure S7A)
and examined the effect of GD on SirT1 phosphorylation. Inter-
estingly, GD stimulated SirT1 phosphorylation at T530 and
T719, but not S14 (Figure 7D). The AMP-activated protein
kinase (AMPK) is activated upon glucose starvation. We found
AICAR (AMPK activator) treatment led to a decreased REGg-
SirT1 binding and a concomitant increase in SirT1 phosphory-
lation at T530 and T719 (Figure 7E). In contrast, treatment of
AMPK inhibitor Compound C inhibited GD-induced SirT1
phosphorylation and REGg-SirT1 dissociation (Figure 7F).
These data suggest that AMPK is responsible for glucose
starvation-induced SirT1 phosphorylation and REGg-SirT1
dissociation.eptember 3, 2013 ª2013 Elsevier Inc. 387
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Figure 7. Energy Starvation Dissociates
REGg-SirT1, Unleashing SirT1 to Associate
with Atg Proteins for Autophagy Activation
(A) 293T cells were transiently transfected with
Flag-SirT1 and REGg, followed by glucose-free
medium (glucose deprivation, GD) treatment.
SirT1 was immunoprecipitated using FLAG-M2
beads, and coprecipitation of REGg was detected
by western blot.
(B) 293T cells were transfected with Flag-REGg,
SirT1, and GFP plasmids followed by 2DG
(12.5 mM) treatment. REGg was immunoprecipi-
tated using FLAG-M2 beads, and coprecipitation
of SirT1 was detected by western blot.
(C) 293T cells were transiently transfected with
Flag-SirT1 and Myc-Atg7, followed by GD treat-
ment. SirT1 was immunoprecipitated using FLAG-
M2 beads, and coprecipitated Atg7 was detected
by western blot with anti-Myc antibody.
(D) Time course of SirT1 phosphorylation
in response to glucose starvation. Flag-SirT1
transfected 293T cells were starved for GD for
indicated times. SirT1 was immunoprecipitated
with FLAG-M2 beads, and phosphorylation of
SirT1 was determined by western blot with
antibodies against SirT1 phosphorylation at
S14, T530, or T719. Relative levels of phos-
phorylated and total SirT1 were quantified by
densitometry of bands and are presented below
the blots.
(E) Activation of AMPK induces SirT1 phosphory-
lation coupled with REGg-SirT1 dissociation. Flag-
SirT1 and REGg were transfected into 293T cells
for 24 hr, and then cells were treated with or
without AMPK activator AICAR (200 mM). SirT1
was immunoprecipitated with FLAG-M2 beads,
and the immunoprecipitated complexes were
examined by western blot. Relative protein levels
were quantified by densitometry of bands and are
presented below the blots.
(F) AMPK inhibitor Compound C prevents glucose
starvation-induced dissociation of REGg-SirT1.
Flag-SirT1 transfected 293T cells were treated
with Compound C (10 mM) for 1 hr, followed by a
0.5–1 hr GD treatment. SirT1 was immunoprecipitated by FLAG-M2 beads, and coprecipitated REGg were determined by western blot.
(G and H) Phosphorylation-mimetic mutation (T530D) in SirT1 regulates its association with REGg and Atg5 proteins. Interaction of Flag-SirT1mutants with REGg
(G) and Atg5 (H) were determined by cotransfection of indicated plasmids into 293T cells, followed by immunoprecipitation using FLAG-M2 beads and western
blot.
(I) SirT1 T530 phosphorylation is responsible for GD-induced REGg-SirT1 dissociation. Flag-SirT1 mutants and REGg cotransfected 293T cells were treated with
or without GD for 1 hr. SirT1 was immunoprecipitated using FLAG-M2 beads, and the immunoprecipitated complexes were examined by western blotting. See
also Figure S7.
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REGg Proteasome Regulates Lipid MetabolismSequence analysis reveals that SirT1 T530, but not T719, is
highly conserved in human and other species (Figure S7B). We
found that SirT1 mutation in T530D, but not in T719D, led to a
decreased SirT1-REGg interaction (Figure 7G), while the SirT1-
T530D mutant had an increased association with Atg5 (Fig-
ure 7H). Dephosphorylation of SirT1 enhanced its association
with REGg in vitro (Figure S7C). Moreover, the phosphoryla-
tion-defective T530A, but not T719A, SirT1 mutant significantly
blocked GD-induced REGg-SirT1 dissociation (Figure 7I). These
results demonstrate that glucose starvation stimulates SirT1
phosphorylation mainly at T530 via AMPK, and this modification
causes dissociation of SirT1-REGg coupled with increased
association of SirT1-Atg5/Atg7, contributing to liberation of
SirT1 to activate autophagy.388 Cell Metabolism 18, 380–391, September 3, 2013 ª2013 ElsevieDISCUSSION
Results described in this study identify a previously unknown
function of the REGg proteasome in regulating autophagy and
lipid metabolism. REGg deficiency leads to autophagy in vivo
and protects mice from HFD-induced liver steatosis. Under
normal conditions, REGg directly binds to SirT1, promotes
SirT1 degradation, displaces Atg proteins from SirT1, and
increases acetylation of Atg proteins, thereby maintaining auto-
phagy at a lower basal level. Upon energy deprivation, REGg dis-
sociates from SirT1 in a phosphorylation-dependent manner,
unleashing SirT1 to interact with Atg proteins and stimulate auto-
phagy. These observations lead us to propose a role for REGg as
a molecular switch regulating autophagy between normal andr Inc.
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REGg Proteasome Regulates Lipid Metabolismstress conditions (Figure S7D). Furthermore, we revealed that
REGg regulates fatty acid-induced hepatic steatosis through a
SirT1- and autophagy-dependent mechanism, and autophagy
is essential for REGg deficiency-mediated prevention of HFD-
induced fatty liver.
Cells are equipped with two major proteolytic systems (pro-
teasome and autophagy). Inhibiting autophagy compromises
degradation of Ub-proteasome substrates (Korolchuk et al.,
2009), whereas proteasome inhibitors activate autophagy, sug-
gesting that the two pathways are functionally coupled (Ding
et al., 2007b). The discovery that REGg deficiency triggers auto-
phagy not only identifies a factor linking proteasomal activity and
autophagy, but also defines a function for a proteasome acti-
vator in shifting the balance between autophagy and the protea-
some system. Since REGg directs a pathway to degrade certain
proteins via an Ub-independent mechanism, our results suggest
that cells may use autophagy as an alternative proteolytic
pathway when the Ub-independent degradation mechanism is
compromised. Recently, we reported that REGg can be acety-
lated by CBP, whereas SirT1 can bind with REGg and deacety-
lates REGg, which inhibits heptamerization of REGg, leading to
reduced REGg capacity (Liu et al., 2013). These observations
suggest a mutual regulation between REGg and SirT1. Previous
studies revealed that starvation could induce a slight but signif-
icant increase of proteasome activity with no upregulation of
ubiquitin-proteasome system (Salem et al., 2007). Given that
starvation markedly reduced REGg-SirT1 interaction, we sug-
gest that the dissociation of SirT1 from REGg may contribute
to starvation-induced increase of proteasome activity through
a posttranslational modification regulatory effect. Identification
of REGg-SirT1 complex has established strong bases for
continued study of the interplays between proteasome and auto-
phagy under various conditions.
This study also provides insights into the function of the REGg
proteasome in the regulation of lipid homeostasis. We have pre-
sented compelling evidence demonstrating the role of REGg in
regulating autophagy via SirT1 under different metabolic condi-
tions and pinpointed the contribution of REGg in hepatic steato-
sis and the pathogenesis of fatty liver during HFD feeding. Since
inhibiting autophagy by CLQ markedly eliminates the protective
roles of REGg deficiency in HFD-induced liver steatosis in vivo,
and SirT1 is required for autophagy stimulation in REGg-defi-
cient cells, we believe that lipid metabolism can be regulated
through the REGg-SirT1-autophagy pathway. However, our
study does not exclude other additional mechanisms mediating
REGg function in lipid homeostasis. Interestingly, we found that
fatty acid stimulates REGg-SirT1 association. Further study on
the correlations between SirT1 and REGg under different meta-
bolic conditions may provide guidance for the treatment of
certain types of metabolic disease.
The REG (or PA28) proteasome activators comprise three
members: a, b, and g. REGa/b primarily localize in cytoplasm
and regulate immunopeptide generation, whereas REGg primar-
ily localizes in nucleus and mainly regulates Ub-independent
degradation of subsets of proteins. A recent study demonstrated
that removal of all three PA28/REG subunits (Triple-REG-KO)
decreased hepatic insulin signaling and resulted inminor hepatic
steatosis under normal diet condition (Otoda et al., 2013). In
contrast, our study using REGg-KO mice revealed a hepaticCell Mesteatosis resistance phenotype under HFD conditions. Triple-
REG-KO activates an unfolded protein response and increases
ER stress in the liver, whereas REGg-KO does not affect ER
homeostatsis. Overexpression of REGg but not REGa/b led to
lipid accumulation. Furthermore, REGg-KO led to a markedly
increased LC3-II accumulation and reduced p62, whereas the
effect of REGg deficiency is not compensated by REGa/b over-
expression. Since REGa/b and REGg have been reported to play
distinct biological roles, with many functions still unknown, it is
likely that simultaneous knockout of three genes may be too
complicated and too early for us to understand the full
mechanisms.
Our study demonstrates that REGg promotes SirT1 degrada-
tion in an Ub-independent manner. A previous report suggested
that JNK1 phosphorylates SirT1 and promotes its Ub-dependent
degradation (Gao et al., 2011). Therefore, SirT1 can be degraded
via both Ub-dependent and -independent pathways. In addition,
we also revealed that GD induces SirT1 phosphorylation on
T530. We estimated the status of SirT1-T530 phosphorylation
under physical conditions in mouse hepatocytes and revealed
that 25% of total SirT1 can be phosphorylated on T530 (T522
in mouse) (data not shown). These observations provide a
possible explanation for why overexpression of a phospho-defi-
cient SirT1-T530A mutant exhibited no significant effect to
its association with REGg, whereas phosphorylation-mimetic
SirT1-T530D mutant markedly reduced its association with
REGg (Figures 7G and 7I). Furthermore, we found that HFD
treatment led to a reduction in hepatic levels of SirT1-T530 phos-
phorylation coupled with a reduction in total SirT1 expression
(Figure S7E). Further study on posttranslational modification of
SirT1 under different conditions may provide new insights into
the SirT1 regulatory network.
Acetylation is emerging as an important autophagy regulatory
mechanism. Tip60 (yeast Esa1) acetylase-mediated Atg1 and
Atg3 acetylation can induce autophagy (Lin et al., 2012; Yi
et al., 2012), P300 acetylase-mediated acetylation of Atg5/Atg7
led to autophagy inhibition (Lee and Finkel, 2009), and SirT1
deacetylase induces autophagy via deacetylation of Atg5/
Atg7/Atg8 proteins (Lee et al., 2008). Upon nitrogen starvation,
autophagy can be induced by Esa1 via Atg3 acetylation (Yi
et al., 2012). Serum starvation triggers signaling from GSK3 to
TIP60 to stimulate Atg1 acetylation and autophagy (Lin et al.,
2012). In our study, glucose starvation induces AMPK-depen-
dent SirT1 phosphorylation on T530, which entails SirT1-REGg
dissociation and thus releases SirT1 to stimulate autophagy.
Interestingly, we detected no significant reduction of REGg-
SirT1 binding after serum starvation (data not shown). These
observations proved that cells use distinct acetylation/deacety-
lation signaling pathways to regulate autophagy in response to
different metabolism changes. Collectively, our observations
indicate that REGg forms a complex with SirT1 and serves as
an important molecular switch for the off/on regulation of auto-
phagy under normal and energy-deprivation conditions.
In conclusion, the present study establishes a molecular
crosstalk between the proteasome activator REGg and SirT1
signaling in the regulation of autophagy and hepatocyte lipid
metabolism. Furthermore, unpublished data in our laboratory
also revealed that REGg-deficient mice exhibit enhanced insulin
sensitivity. Thus, it is tempting to speculate that downregulationtabolism 18, 380–391, September 3, 2013 ª2013 Elsevier Inc. 389
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REGg Proteasome Regulates Lipid Metabolismof REGg also may protect against diabetes. Our findings that
REGg regulates autophagy and lipid metabolism make it an
attractive drug target since pharmacological manipulation of
REGg could have potential benefits for metabolic disorders
such as liver steatosis, diabetes, and age-related diseases.
EXPERIMENTAL PROCEDURES
Animal Experimentation
REGg KO mice were kindly provided by Dr. John J. Monaco at University of
Cincinnati (Barton et al., 2004). All mice used were C57BL/6 male mice.
REGg-WT and -KO mice were fed either with a standard CD or with a HFD
(D12492 with 60 kcal% fat; Research Diets, Inc.) starting when the mice
were 3 weeks of age and for a total of 19 additional weeks. Animals are treated
according to high ethical and scientific standards with oversight by the Animal
Center at East China Normal University.
Measurement of Liver/Body Weight and Food Intake
Mice had ad libitum access to either normal CD or HFD and water. Food intake
of REGg-WT or REGg-KO male mice (n = 4) on HFD was monitored weekly at
17–18 weeks (one pair of REGg-WT and -KO littermate mice monitored
1 week, the other three pairs monitored for 2 weeks) after HFD. Body weight
was determined every 2 weeks. Mouse liver/body weight was measured after
being sacrificed.
Cell Lines, Plasmids, and Reagents
HeLa, H1299, HepG2, HEK293T, REGg-WT, and REGg-KO MEF cells were
maintained in DMEM with 10% fetal bovine serum. REGg-knockdown,
SirT1-knockdown, or vector control stable cell lines were established by tran-
sient transfection and selected with puromycin. Primary hepatocyteswere iso-
lated as described previously (Liu et al., 2012). GFP-LC3 and Myc-Atg5/Atg7/
Atg8 plasmids were kind gifts from Toren Finkel (NIH). SirT1-knockdown plas-
mids were previously generated (Wang et al., 2006). Cycloheximide, 2DG,
AMPK activator (AICAR), and inhibitor (Compound C) were obtained from
Sigma. Antibodies were purchased from Sigma (LC3, p62, REGg, Flag-tag,
and b-actin), Santa Cruz Biotechnology (GFP, SirT1, and Myc-tag), Cell
Signaling Technology (Ac-K-103-lysine), and Vector Laboratories (goat anti-
rabbit IgG).
Analysis of Autophagy by Microscopy
Autophagy was visualized by GFP-LC3 transfection followed by confocal
microscopy. For electron microscopy investigations, cells or liver tissues
were fixed with 2.5% glutaraldehyde for 3 hr, rinsed in PBS, postfixed in 1%
OsO4, dehydrated, and embedded in Epon. Ultrathin sections were con-
trasted with uranyl acetate and lead citrate and photographed in a JEM-
2100 transmission electron microscope.
Immunostaining
Immunohistochemical staining in tissues was performed using anti-SirT1
antibody and visualized as previously described (Liu et al., 2010).
Immunoprecipitation and GST Pull-Down Assay
Cell lysate preparation, protein immunoprecipitation, and GST pull-down
assay were performed as previously described (Hu et al., 2012).
Lipid Accumulation and Measurement
Cells were incubated in the absence or presence of sodium oleate or
oleate/palmitate (2:1) in culture medium supplemented with 1% fatty acid-
free BSA. To measure TG, the lipids were extracted from cell lysates using
a chloroform/methanol (2:1) mixture. TG was determined using Serum Tri-
glyceride Determination Kit (TR0100, Sigma). For lipid droplet staining, cells
were fixed with 10% formalin and stained with oil red O working solution
and visualized under the bright-field microscope. Alternatively, BODIPY
493/503 (0.01 mg/ml) in PBS was applied to lipid droplet stain for 15 min
and visualized by fluorescence microscopy. Hepatic TGs were extracted as
previously described (Liu et al., 2012). Blood samples were obtained for
serum TG measurements.390 Cell Metabolism 18, 380–391, September 3, 2013 ª2013 ElsevieStatistical Analyses
Results are shown asmean ± SD. Differences were considered significant with
a p value < 0.05 using Student’s two-tailed t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.cmet.2013.08.012.
ACKNOWLEDGMENTS
This work was supported in part by National Institutes of Health
(R01CA131914 to X.L., R01HL51586 to L.C., and NICHD-HD8188 to
B.W.O), Norman Hackerman Advanced Research Program (1082318401)
and the Pilot/Feasibility Program of the Diabetes Research Center at Baylor
College of Medicine (P30-DK079638) to X.L., Cancer Prevention & Research
Institute of Texas Core Facility Support Awards (RP120092) and NCI Cancer
Center Support Grant to the Proteomics Shared Resource (P30CA125123) to
D.P.E., and grants from National Natural Science Foundation of China
(31201044, 31071248, 31171361, 81372146, 81261120555, and
81071657), National Basic Research Program of China (2009CB918401,
2009CB918402, and 2011CB504200), and the Science and Technology
Commission of Shanghai Municipality (11DZ2260300). The authors would
like to thank Mrs. Myra Costello at the Proteomics Shared Resource for
her technical support.
Received: February 21, 2013
Revised: June 22, 2013
Accepted: August 9, 2013
Published: September 3, 2013
REFERENCES
Barton, L.F., Runnels, H.A., Schell, T.D., Cho, Y., Gibbons, R., Tevethia, S.S.,
Deepe, G.S., Jr., and Monaco, J.J. (2004). Immune defects in 28-kDa protea-
some activator gamma-deficient mice. J. Immunol. 172, 3948–3954.
Bernier, M., Paul, R.K., Martin-Montalvo, A., Scheibye-Knudsen, M., Song, S.,
He, H.J., Armour, S.M., Hubbard, B.P., Bohr, V.A., Wang, L., et al. (2011).
Negative regulation of STAT3 protein-mediated cellular respiration by SIRT1
protein. J. Biol. Chem. 286, 19270–19279.
Brunet, A., Sweeney, L.B., Sturgill, J.F., Chua, K.F., Greer, P.L., Lin, Y., Tran,
H., Ross, S.E., Mostoslavsky, R., Cohen, H.Y., et al. (2004). Stress-dependent
regulation of FOXO transcription factors by the SIRT1 deacetylase. Science
303, 2011–2015.
Chen, W.Y., Wang, D.H., Yen, R.C., Luo, J., Gu, W., and Baylin, S.B. (2005).
Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent
DNA-damage responses. Cell 123, 437–448.
Czaja, M.J. (2010). Autophagy in health and disease. 2. Regulation of lipid
metabolism and storage by autophagy: pathophysiological implications. Am.
J. Physiol. Cell Physiol. 298, C973–C978.
Ding, W.X., Ni, H.M., Gao, W., Hou, Y.F., Melan, M.A., Chen, X., Stolz, D.B.,
Shao, Z.M., and Yin, X.M. (2007a). Differential effects of endoplasmic reticulum
stress-induced autophagy on cell survival. J. Biol. Chem. 282, 4702–4710.
Ding, W.X., Ni, H.M., Gao, W., Yoshimori, T., Stolz, D.B., Ron, D., and Yin, X.M.
(2007b). Linking of autophagy to ubiquitin-proteasome system is important for
the regulation of endoplasmic reticulum stress and cell viability. Am. J. Pathol.
171, 513–524.
Dubiel, W., Pratt, G., Ferrell, K., and Rechsteiner, M. (1992). Purification of an
11 S regulator of themulticatalytic protease. J. Biol. Chem. 267, 22369–22377.
Fu, S., Yang, L., Li, P., Hofmann, O., Dicker, L., Hide,W., Lin, X., Watkins, S.M.,
Ivanov, A.R., and Hotamisligil, G.S. (2011). Aberrant lipid metabolism disrupts
calcium homeostasis causing liver endoplasmic reticulum stress in obesity.
Nature 473, 528–531.
Fu, S., Fan, J., Blanco, J., Gimenez-Cassina, A., Danial, N.N., Watkins, S.M.,
and Hotamisligil, G.S. (2012). Polysome profiling in liver identifies dynamicr Inc.
Cell Metabolism
REGg Proteasome Regulates Lipid Metabolismregulation of endoplasmic reticulum translatome by obesity and fasting. PLoS
Genet. 8, e1002902.
Gao, Z., Zhang, J., Kheterpal, I., Kennedy, N., Davis, R.J., and Ye, J. (2011).
Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun
N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in
obesity. J. Biol. Chem. 286, 22227–22234.
Guarente, L. (2000). Sir2 links chromatin silencing, metabolism, and aging.
Genes Dev. 14, 1021–1026.
Hu, C., Zhang, S., Gao, X., Gao, X., Xu, X., Lv, Y., Zhang, Y., Zhu, Z., Zhang, C.,
Li, Q., et al. (2012). Roles of Kruppel-associated Box (KRAB)-associated
Co-repressor KAP1 Ser-473 Phosphorylation in DNA Damage Response.
J. Biol. Chem. 287, 18937–18952.
Korolchuk, V.I., Mansilla, A., Menzies, F.M., and Rubinsztein, D.C. (2009).
Autophagy inhibition compromises degradation of ubiquitin-proteasome
pathway substrates. Mol. Cell 33, 517–527.
Kroemer, G., Marin˜o, G., and Levine, B. (2010). Autophagy and the integrated
stress response. Mol. Cell 40, 280–293.
Lee, I.H., and Finkel, T. (2009). Regulation of autophagy by the p300 acetyl-
transferase. J. Biol. Chem. 284, 6322–6328.
Lee, I.H., Cao, L., Mostoslavsky, R., Lombard, D.B., Liu, J., Bruns, N.E.,
Tsokos, M., Alt, F.W., and Finkel, T. (2008). A role for the NAD-dependent
deacetylase Sirt1 in the regulation of autophagy. Proc. Natl. Acad. Sci. USA
105, 3374–3379.
Li, X., Lonard, D.M., Jung, S.Y., Malovannaya, A., Feng, Q., Qin, J., Tsai, S.Y.,
Tsai, M.J., and O’Malley, B.W. (2006). The SRC-3/AIB1 coactivator is
degraded in a ubiquitin- and ATP-independent manner by the REGgamma
proteasome. Cell 124, 381–392.
Li, X., Amazit, L., Long, W., Lonard, D.M., Monaco, J.J., and O’Malley, B.W.
(2007). Ubiquitin- and ATP-independent proteolytic turnover of p21 by the
REGgamma-proteasome pathway. Mol. Cell 26, 831–842.
Lin, S.Y., Li, T.Y., Liu, Q., Zhang, C., Li, X., Chen, Y., Zhang, S.M., Lian, G.,
Ruan, K., Wang, Z., et al. (2012). GSK3-TIP60-ULK1 signaling pathway links
growth factor deprivation to autophagy. Science 336, 477–481.
Liu, J., Yu, G., Zhao, Y., Zhao, D., Wang, Y., Wang, L., Liu, J., Li, L., Zeng, Y.,
Dang, Y., et al. (2010). REGgamma modulates p53 activity by regulating its
cellular localization. J. Cell. Sci. 123, 4076–4084.
Liu, Y., Zhou, D., Zhang, F., Tu, Y., Xia, Y., Wang, H., Zhou, B., Zhang, Y., Wu,
J., Gao, X., et al. (2012). Liver Patt1 deficiency protects male mice from age-
associated but not high-fat diet-induced hepatic steatosis. J. Lipid Res. 53,
358–367.
Liu, J., Wang, Y., Li, L., Zhou, L., Wei, H., Zhou, Q., Liu, J., Wang, W., Ji, L.,
Shan, P., et al. (2013). Site-specific acetylation of the proteasome activator
REGg directs its heptameric structure and functions. J. Biol. Chem. 288,
16567–16578.
Luo, J., Nikolaev, A.Y., Imai, S., Chen, D., Su, F., Shiloh, A., Guarente, L., and
Gu, W. (2001). Negative control of p53 by Sir2alpha promotes cell survival
under stress. Cell 107, 137–148.
Ma, C.P., Slaughter, C.A., and DeMartino, G.N. (1992). Identification, purifica-
tion, and characterization of a protein activator (PA28) of the 20 S proteasome
(macropain). J. Biol. Chem. 267, 10515–10523.
Mizushima, N. (2007). Autophagy: process and function. Genes Dev. 21, 2861–
2873.
Murata, S., Kawahara, H., Tohma, S., Yamamoto, K., Kasahara, M.,
Nabeshima, Y., Tanaka, K., and Chiba, T. (1999). Growth retardation in miceCell Melacking the proteasome activator PA28gamma. J. Biol. Chem. 274, 38211–
38215.
Nasrin, N., Kaushik, V.K., Fortier, E., Wall, D., Pearson, K.J., de Cabo, R., and
Bordone, L. (2009). JNK1 phosphorylates SIRT1 and promotes its enzymatic
activity. PLoS ONE 4, e8414.
Nemoto, S., Fergusson, M.M., and Finkel, T. (2004). Nutrient availability regu-
lates SIRT1 through a forkhead-dependent pathway. Science 306, 2105–2108.
Otoda, T., Takamura, T., Misu, H., Ota, T., Murata, S., Hayashi, H., Takayama,
H., Kikuchi, A., Kanamori, T., Shima, K.R., et al. (2013). Proteasome dysfunc-
tion mediates obesity-induced endoplasmic reticulum stress and insulin resis-
tance in the liver. Diabetes 62, 811–824.
Pfluger, P.T., Herranz, D., Velasco-Miguel, S., Serrano, M., and Tscho¨p, M.H.
(2008). Sirt1 protects against high-fat diet-induced metabolic damage. Proc.
Natl. Acad. Sci. USA 105, 9793–9798.
Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., de
Oliveira, R.M., Leid, M., McBurney, M.W., and Guarente, L. (2004). Sirt1 pro-
motes fat mobilization in white adipocytes by repressing PPAR-gamma.
Nature 430, 921–921.
Purushotham, A., Schug, T.T., Xu, Q., Surapureddi, S., Guo, X.M., and Li, X.L.
(2009). Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and
results in hepatic steatosis and inflammation. Cell Metab. 9, 327–338.
Qiang, L., Wang, L.H., Kon, N., Zhao, W.H., Lee, S., Zhang, Y.Y., Rosenbaum,
M., Zhao, Y.M., Gu, W., Farmer, S.R., and Accili, D. (2012). Brown remodeling
of white adipose tissue by SirT1-dependent deacetylation of Pparg. Cell 150,
620–632.
Salem, M., Silverstein, J., Rexroad, C.E., 3rd, and Yao, J. (2007). Effect of
starvation on global gene expression and proteolysis in rainbow trout
(Oncorhynchus mykiss). BMC Genomics 8, 328.
Singh, R., and Cuervo, A.M. (2012). Lipophagy: connecting autophagy and
lipid metabolism. Int. J. Cell Biol. 2012, 282041.
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K.,
Cuervo, A.M., and Czaja, M.J. (2009). Autophagy regulates lipid metabolism.
Nature 458, 1131–1135.
Sinha, R.A., You, S.H., Zhou, J., Siddique, M.M., Bay, B.H., Zhu, X., Privalsky,
M.L., Cheng, S.Y., Stevens, R.D., Summers, S.A., et al. (2012). Thyroid
hormone stimulates hepatic lipid catabolism via activation of autophagy.
J. Clin. Invest. 122, 2428–2438.
Wang, C., Chen, L., Hou, X., Li, Z., Kabra, N., Ma, Y., Nemoto, S., Finkel, T., Gu,
W., Cress, W.D., and Chen, J. (2006). Interactions between E2F1 and SirT1
regulate apoptotic response to DNA damage. Nat. Cell Biol. 8, 1025–1031.
Wo´jcik, C. (1999). Proteasome activator subunit PA28 alpha and related Ki
antigen (PA28 gamma) are absent from the nuclear fraction purified by sucrose
gradient centrifugation. Int. J. Biochem. Cell Biol. 31, 273–276.
Yang, L., Li, P., Fu, S.N., Calay, E.S., and Hotamisligil, G.S. (2010). Defective
hepatic autophagy in obesity promotes ER stress and causes insulin resis-
tance. Cell Metab. 11, 467–478.
Yi, C., Ma, M., Ran, L., Zheng, J., Tong, J., Zhu, J., Ma, C., Sun, Y., Zhang, S.,
Feng, W., et al. (2012). Function and molecular mechanism of acetylation in
autophagy regulation. Science 336, 474–477.
Zhang, Y., Goldman, S., Baerga, R., Zhao, Y., Komatsu, M., and Jin, S.K.
(2009). Adipose-specific deletion of autophagy-related gene 7 (atg7) in mice
reveals a role in adipogenesis. Proc. Natl. Acad. Sci. USA 106, 19860–19865.
Zhao,W., Kruse, J.P., Tang, Y., Jung, S.Y., Qin, J., andGu,W. (2008). Negative
regulation of the deacetylase SIRT1 by DBC1. Nature 451, 587–590.tabolism 18, 380–391, September 3, 2013 ª2013 Elsevier Inc. 391
